Jason Kelly, Ginkgo Bioworks CEO (Kyle Grillot/Bloomberg via Getty Images)

Gink­go part­ners up with Sen­si­ble Biotech­nolo­gies to forge mR­NA man­u­fac­tur­ing plat­form

Since the suc­cess­ful, glob­al re­lease of mR­NA-based Covid-19 vac­cines, the mR­NA plat­form has be­come a top fo­cus for bio­phar­ma com­pa­nies. Gink­go Bioworks’ lat­est part­ner­ship looks …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.